Literature DB >> 29398824

Diagnostic and Prognostic Value of Serum Thymidine Kinase 1 in Cancer Patients.

Yantao Li1, Rongna Wei2, Shilin Song3.   

Abstract

Entities:  

Year:  2017        PMID： 29398824      PMCID： PMC5786609          DOI： 10.1007/s12288-017-0812-1

Source DB:  PubMed          Journal:  Indian J Hematol Blood Transfus        ISSN： 0971-4502            Impact factor:   0.900


× No keyword cloud information.
  7 in total

1.  The use of radiation therapy appears to improve outcome in patients with malignant primary tracheal tumors: a SEER-based analysis.

Authors:  Liyi Xie; Min Fan; Nathan C Sheets; Ronald C Chen; Guo-Liang Jiang; Lawrence B Marks
Journal:  Int J Radiat Oncol Biol Phys       Date:  2012-02-24       Impact factor: 7.038

2.  3'-deoxy-3'-[18F]fluorothymidine positron emission tomography for response assessment in soft tissue sarcoma: a pilot study to correlate imaging findings with tissue thymidine kinase 1 and Ki-67 activity and histopathologic response.

Authors:  Matthias R Benz; Johannes Czernin; Martin S Allen-Auerbach; Sarah M Dry; Piriya Sutthiruangwong; Claudio Spick; Caius Radu; Wolfgang A Weber; William D Tap; Fritz C Eilber
Journal:  Cancer       Date:  2011-10-21       Impact factor: 6.860

3.  Variability of Proliferation and Diffusion in Different Lung Cancer Models as Measured by 3'-Deoxy-3'-¹⁸F-Fluorothymidine PET and Diffusion-Weighted MR Imaging.

Authors:  Sonja Schelhaas; Lydia Wachsmuth; Thomas Viel; Davina J Honess; Kathrin Heinzmann; Donna-Michelle Smith; Sven Hermann; Stefan Wagner; Michael T Kuhlmann; Carsten Müller-Tidow; Klaus Kopka; Otmar Schober; Michael Schäfers; Richard Schneider; Eric O Aboagye; John Griffiths; Cornelius Faber; Andreas H Jacobs
Journal:  J Nucl Med       Date:  2014-04-28       Impact factor: 10.057

4.  Comparison of diagnostic and prognostic performance of two assays measuring thymidine kinase 1 activity in serum of breast cancer patients.

Authors:  Benjamin Nisman; Tanir Allweis; Luna Kadouri; Bela Mali; Tamar Hamburger; Mario Baras; Simon Gronowitz; Tamar Peretz
Journal:  Clin Chem Lab Med       Date:  2013-02       Impact factor: 3.694

5.  Serum thymidine kinase 1 activity in solid tumor (breast and colorectal cancer) patients treated with adjuvant chemotherapy.

Authors:  M Bolayirli; C Papila; G G Korkmaz; B Papila; F Aydoğan; A Karataş; H Uzun
Journal:  J Clin Lab Anal       Date:  2013-05       Impact factor: 2.352

6.  Malignant peripheral nerve sheath tumors: prognostic impact of rhabdomyoblastic differentiation (malignant triton tumors), neurofibromatosis 1 status and location.

Authors:  S C Kamran; S A Howard; A B Shinagare; K M Krajewski; J P Jagannathan; J L Hornick; N H Ramaiya
Journal:  Eur J Surg Oncol       Date:  2012-10-18       Impact factor: 4.424

7.  DPYD, TYMS, TYMP, TK1, and TK2 genetic expressions as response markers in locally advanced rectal cancer patients treated with fluoropyrimidine-based chemoradiotherapy.

Authors:  Ming-Yii Huang; Chan-Han Wu; Chun-Ming Huang; Fu-Yen Chung; Ching-Wen Huang; Hsiang-Lin Tsai; Chin-Fan Chen; Shiu-Ru Lin; Jaw-Yuan Wang
Journal:  Biomed Res Int       Date:  2013-12-23       Impact factor: 3.411
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.